💊 Composition
Febunorm-40 Tablets
Active Ingredient: Febuxostat 40 mg
Category: Xanthine oxidase inhibitor
Form: Oral Tablet
📌 Key Indications
Febunorm-40 is primarily indicated in:
Chronic Gout – prevention of acute gout flares
Hyperuricemia – high uric acid levels in adults
Urate Nephropathy – kidney complications caused by uric acid
Prevention of tophi formation
Post-chemotherapy uric acid management (off-label use)
🧠 Benefits
✔️ Effectively lowers serum uric acid levels
✔️ Reduces frequency of gout attacks
✔️ Safer option for patients intolerant to allopurinol
✔️ Long-term control of uric acid crystals
✔️ Improves joint mobility and comfort
🧪 Mechanism of Action
Febuxostat is a non-purine selective inhibitor of the enzyme xanthine oxidase, responsible for converting hypoxanthine and xanthine into uric acid. By inhibiting this process, Febunorm-40 helps to:
Reduce production of uric acid
Maintain target serum urate levels (<6 mg/dL)
Prevent crystal deposition in joints and tissues
⚠️ Dosage & Administration
Typical Adult Dose: One tablet of Febunorm-40 once daily
Monitoring: Serum uric acid levels should be monitored regularly
Note: Initial therapy may trigger gout flares; prophylactic NSAIDs or colchicine may be advised
❗Warnings & Precautions
Not recommended in severe hepatic impairment
Caution in cardiovascular disease
Avoid abrupt discontinuation
Regular liver function tests advised
Not for pediatric or pregnant use without medical supervision
💥 Side Effects
Mild skin rashes
Liver enzyme elevation
Nausea or diarrhea
Rare: Cardiovascular thrombotic events (monitor high-risk patients)
📦 Storage Instructions
Store below 30°C
Protect from moisture and direct sunlight
Keep away from children
💼 Pharma Franchise Opportunity
Start your pharma business with Febunorm-40 by Minova Life Sciences.
High-demand uric acid segment
Monopoly rights available
WHO-GMP certified manufacturing
Marketing and promotional support provided
🏥 About Minova Life Sciences
Minova Life Sciences is a trusted pharmaceutical company committed to innovation and therapeutic excellence. With a strong portfolio in neuropsychiatry, orthopedics, urology, and internal medicine, Minova empowers patients and partners with quality-driven, science-backed formulations.
📞 Connect with Minova for Franchise Inquiry
📱 Phone: +91-9845329972
📧 Email: info@minovalifesciences.com
🌐 Website: www.minovalifesciences.com
